Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Hualan Biological Engineering Inc.    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/25/2020 11/26/2020 11/27/2020 11/30/2020 12/01/2020 Date
41.26 40.5 41.66 43.04 44.24 Last
23259870 19903800 24253040 34783540 34380400 Volume
-2.53% -1.84% +2.86% +3.31% +2.79% Change
Financials
Sales 2020 4 778 M 727 M 727 M
Net income 2020 1 555 M 237 M 237 M
Net cash position 2020 1 009 M 153 M 153 M
P/E ratio 2020 47,5x
Yield 2020 0,84%
Sales 2021 5 493 M 836 M 836 M
Net income 2021 1 901 M 289 M 289 M
Net cash position 2021 2 063 M 314 M 314 M
P/E ratio 2021 39,4x
Yield 2021 0,94%
Capitalization 78 521 M 11 938 M 11 951 M
EV / Sales 2020 16,2x
EV / Sales 2021 13,9x
Nbr of Employees 2 417
Free-Float 48,6%
More Financials
Company
Hualan Biological Engineering, Inc. specializes in the research, development, manufacturing and marketing of biological and sanguine products and vaccines. The group's products include immunoglobulin for intravenous injections, lyophilized surgical fibrin, lyophilized thrombin for external use, vaccines against cold, etc. 
More about the company
Notations Surperformance© of Hualan Biological Engineering Inc.
Trading Rating : Investor Rating :
More Ratings
All news about HUALAN BIOLOGICAL ENGINEERING INC.
02:00aSamsung may discontinue high-end Galaxy Note smartphones - sources
RE
10/08Samsung Electronics profit likely at two-year high after Huawei orders, phone..
RE
10/07Samsung Elec profit likely at 2-year high after Huawei orders, phone recovery
RE
08/06HUALAN BIOLOGICAL ENGINEERING INC. : half-yearly earnings release
07/27Verdict in first 1MDB case packs risk for Malaysian government
RE
04/02HUALAN BIOLOGICAL ENGINEERING INC. : annual earnings release
02/26NEW CHINESE BILLIONAIRES OUTPACE U.S : Hurun
RE
More news
News in other languages on HUALAN BIOLOGICAL ENGINEERING INC.
09/04Kretschmann mahnt einheitliches Vorgehen bei Fan-Frage an
08/11BVB-Profi Delaney sieht Dänemark bei Fan-Rückkehr als Vorbild
08/06HUALAN BIOLOGICAL ENGINEERING INC. : Veröffentlichung des Halbjahresergebnisses
08/06HUALAN BIOLOGICAL ENGINEERING INC. : publication des résultats semestriels
04/02HUALAN BIOLOGICAL ENGINEERING INC. : Veröffentlichung des Jahresergebnisses
More news
Chart HUALAN BIOLOGICAL ENGINEERING INC.
Duration : Period :
Hualan Biological Engineering Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HUALAN BIOLOGICAL ENGINEERING INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Average target price 54,28 CNY
Last Close Price 43,04 CNY
Spread / Highest target 51,0%
Spread / Average Target 26,1%
Spread / Lowest Target -25,8%
EPS Revisions
Managers
NameTitle
Kang An Chairman & General Manager
Chao Yuan Ma Chairman-Supervisory Board
Jun Min Xie Chief Financial Officer & Board Secretary
Bei Fan Director & Executive Deputy General Manager
Qi Ping Wang Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
HUALAN BIOLOGICAL ENGINEERING INC.59.18%11 938
GILEAD SCIENCES, INC.-6.63%76 052
VERTEX PHARMACEUTICALS4.02%59 224
REGENERON PHARMACEUTICALS37.43%54 464
WUXI APPTEC CO., LTD.56.53%38 135
BIONTECH SE266.71%29 915